A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Clinical trial NCT04380701 · COMPLETED

Trial details

NCT number: NCT04380701
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Infections, Respiratory Virus Diseases Infection Viral Vaccine Adverse Reaction RNA Virus Infections Protection Against COVID-19 and Infections With SARS CoV 2

Start date: 2020-04-23
Primary completion: 2021-06-30
Enrollment: 512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.